William Blair analyst Jason Ader reiterated a Buy rating on Varonis Systems (VRNS – Research Report) today. The company’s shares opened today ...

The embedded payments and digital card company agreed to buy European electronic payments provider TransactPay for about $47 ...

In a report released today, Ryan Daniels from William Blair maintained a Hold rating on Teladoc (TDOC – Research Report). The company’s shares ...

Analysts at William Blair upped their FY2025 EPS estimates for Straumann in a report issued on Monday, February 24th. William Blair analyst B. Vazquez now forecasts that the company will post earnings ...

Research analysts at William Blair increased their Q1 2025 earnings estimates for shares of Tactile Systems Technology in a note issued to investors on Monday, February 24th. William Blair analyst M.

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for General Dynamics (NYSE:GD) from ...

William Blair downgrades Booz Allen, CACI International, Leidos, Parsons and General Dynamics on the heightened risk of ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

The new fund will invest in a niche subset of emerging markets that are 'more challenging for investors to access' ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The largest contributor to the rating is the stability of the management team. Specifically, the fund has not seen a ...